Archive for the ‘Cervical Cancer / HPV Vaccine’ Category

Advaxis Scientists Publish Research Of Listeria Monocytogenes-Based Vaccine For Prostate Cancer In Latest Edition Of Cancer Immunology & Immunotherapy

Monday, March 17th, 2008

Drs. Vafa Shahabi (Advaxis Inc. OTCBB: ADXS) and Yvonne Paterson (University of Pennsylvania) led a team (the "Team") of six leading research microbiologists and published findings on the potential use of a Listeria monocytogenes-based vaccine for prostate cancer ("pCa"). The Team developed and characterized a recombinant live attenuated Listeria monocytogenes/PSA ...

Actions Taken On Women’s Health-Related Legislation In Mo., Neb., Tenn.

Monday, March 17th, 2008

The following highlights recent state news about women's health-related legislation. Missouri: The Senate preliminarily approved a bill (SB 778) Tuesday that would require parents of girls entering the sixth grade be sent information on how HPV is transmitted, the virus' symptoms and its link to cervical cancer, as well as ...

Actions Taken On Women’s Health-Related Issues In Colorado, Kentucky, Massachusetts, Nebraska

Monday, March 17th, 2008

The following highlights recent state news about women's health-related issues. Colorado: Denver City Attorney David Fine on Wednesday announced that antiabortion groups seeking to protest at the Democratic National Convention this summer may apply for permits beginning March 3, the AP/cbs4denver.com reports. The Christian Defense Coalition and the group Survivors ...

Survey Shows Most Women Can’t Separate Fact From Fiction When It Comes To Cervical Cancer Prevention

Monday, March 17th, 2008

Despite growing awareness of HPV (human papillomavirus), the primary cause of cervical cancer, a new survey released by the National Association of Nurse Practitioners in Women's Health (NPWH) found that many women remain in the dark about what it takes to prevent the disease. Despite the fact that there ...

Actions Taken On Women’s Health Legislation, Policy In Ariz., Colo., Mass., Mich., N.M.

Monday, March 17th, 2008

The following highlights recent state and local news about women's health policy and legislation. Arizona: On Wednesday, the House Health Committee approved 5-4 a measure (HB 2769) that would "essentially mirror" the federal ban (S 3) on so-called "partial-birth" abortion, an antiabortion lobbyist who helped draft the measure said, the ...

Stress May Increase A Woman’s Risk Of Developing Cervical Cancer

Monday, March 17th, 2008

A woman's daily stress can reduce her ability to fight off a common sexually transmitted disease and increase her risk of developing the cancer it can cause, according to a new study. No such association is seen, however, between past major life events, such as divorce or job loss, and ...

FDA Approves CytoCore’s SoftPAP(TM) Cervical Cell Collector

Monday, March 17th, 2008

CytoCore Inc. (OTCBB:CYOE), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, announced that the U.S. Food and Drug Administration has approved the company's 510(k) submission to sell CytoCore's SoftPAP™ cervical cell collector. The SoftPAP collects more comprehensive and complete cervical cell specimens for ...

Sustained Efficacy Of Gardasil Against Early Cervical Lesions, Precancerous Vulvar And Vaginal Lesions, And Genital Warts In Large Phase III Studies

Friday, March 14th, 2008

A combined analysis of three phase II/III clinical studies which enrolled more than 18,000 young women* confirmed that the quadrivalent (6,11,16,18) vaccine Gardasil®? had a sustained efficacy of 96%? against early cervical lesions (CIN1§), 99%** against genital warts and 100%??against early and precancerous vulvar and vaginal lesions (VIN??1 and 2/3, ...

Mo. Senate Approves Bill To Pay For HPV Information, Vaccination For Sixth Graders

Thursday, March 13th, 2008

The Missouri Senate last week passed a bill (SB 778) that would send parents of sixth-grade girls in public schools information about the connection between HPV and cervical cancer and the availability of the HPV immunization, the St. Louis Post-Dispatch reports. The bill, sponsored by state Sen. Jolie Justus (D), also ...

Third Wave’s HPV Clinical Trial Achieves Primary Clinical Endpoints

Thursday, March 13th, 2008

Third Wave Technologies Inc. (NASDAQ: TWTI) announced that the company achieved all primary clinical endpoints in the clinical trial for its human papillomavirus (HPV) tests. The company expects to submit the trial results to the U.S. Food and Drug Administration for both its high-risk and 16/18 genotyping products in April. ...

GSK HPV Vaccine Cervarix Effective For More Than Six Years, Company Says

Thursday, March 13th, 2008

GlaxoSmithKline's human papillomavirus vaccine Cervarix provides significant protection against the four most common cancer-causing HPV strains for 6.4 years, according to data from a follow-up study, Reuters reports. The company presented the new data at the Society of Gynecologic Oncologists' annual meeting in Tampa, Fla. (Hirschler, Reuters, 3/10).GSK reported that ...

GARDASIL Will Spare Thousands A Diagnosis Of Cell Abnormality That May Lead To More Tests And Possibly Surgery

Tuesday, March 11th, 2008

A significant drop in abnormal Pap test results happened after girls and women were given a vaccine to prevent cervical cancer, according to a researcher at the University of Alabama at Birmingham (UAB).The findings show the vaccine, named GARDASIL, appears to prevent the development of cell changes that lead to ...

GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection For More Than Six Years

Tuesday, March 11th, 2008

New data demonstrate that GlaxoSmithKline's (NYSE: GSK) cervical cancer candidate vaccine, CERVARIX(R) provides significant protection for women against the four most common cancer- causing human papillomavirus types for nearly six and a half years, the longest duration of protection reported to date. Over this time, the cervical cancer candidate vaccine ...

Society Of Gynecologic Oncologists 39th Annual Meeting On Women’s Cancer To Include Sessions On HPV And Cervical Cancer

Tuesday, March 11th, 2008

It has been almost two years since the first vaccine to prevent cervical cancer was approved for regular clinical use, and the Society of Gynecologic Oncologists (SGO), the professional association for experts in women's cancer, will take a critical look at HPV and Cervical Cancer as well as ...

Miami Group Works To Address High Cervical Cancer Rate Among Haitian-American Women

Monday, March 10th, 2008

A group called Haitian Women of Miami is working to lower the rate of cervical cancer among Florida's Haitian-American population. Haitian-American women are three times more likely than other women to develop cervical cancer, according to the Florida Cancer Data System, the Miami Herald reports.According to the Herald, Haitian-American women ...